The short answer
Review ashwagandha before combining it with alprazolam. Some preparations cause drowsiness, and official guidance identifies possible interactions with sedatives.
What this answer covers
Oral Withania somnifera; root-extract trial does not establish all leaf/root or mixture effects.
- Supplement or preparation
- Withania somnifera
- Medication ingredient
- alprazolam
Why a review is sensible
NCCIH notes drowsiness with some ashwagandha preparations and possible interactions with sedatives. Alprazolam itself can impair coordination and alertness.
A sleep study is not co-use evidence
A specific root-extract sleep trial reported no adverse events, but excluded regular medication users. It therefore cannot establish safety for someone taking alprazolam.
Bring the actual formulation
Show the pharmacist the species, plant part, extract and other ingredients. No universal ashwagandha dose or dosing gap has been shown safe with alprazolam.
Protect your alertness
Alprazolam can impair coordination and alertness. Avoid driving when affected. Seek urgent help for severe difficulty waking or breathing, and tell the prescriber about all other sedating medicines and alcohol.
Evidence and practical considerations
Side effects & toxicity
Conditional alertness precaution follows supplement guidance and exact alprazolam CNS effects; no measured exact-pair risk rate.
- Exact scope
- Oral Withania somnifera; root-extract trial does not establish all leaf/root or mixture effects. with Exact oral alprazolam; no blanket benzodiazepine metabolic or route transfer.
- Medication form and route
- oral; other cannabis routes only if explicitly discussed
- Timing or duration
- Exact duration and dose depend on source; single-dose and chronic use are distinguished.
What remains uncertain
- No exact human co-use trial. Sleep trial excluded regular medication users and people with seizures or relevant neurological illness.
Factors that may matter: preparation and plant part; dose; other medicines; baseline alertness; clinical indication.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral alprazolam.
CNS depression, impaired coordination and alertness can occur; concomitant CNS depressants require caution. Dependence and withdrawal risks require individualized tapering rather than abrupt cessation. Metabolism involves CYP3A; inhibitors and inducers may alter exposure. Not the same metabolic pathway profile as oxazepam or temazepam.
How this applies: Exact RxNorm ingredient and oral formulation confirmed in original label; use exact indication and metabolic boundaries.
Does not quantify the requested botanical interaction risks, prove every herb is sedating, or establish a protective supplement interval.
Source 2: official guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: People considering the specified supplement.
Some preparations can cause drowsiness; possible interaction with sedatives. Products and studied preparations vary.
How this applies: Preparation-specific context; not a directly measured alprazolam interaction.
No direct alprazolam study; short-term safety observations do not establish long-term safety.
Source 3: randomized placebo-controlled trial
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 60 adults enrolled with insomnia and anxiety.
Some sleep outcomes improved; no adverse events were reported. Morning alertness did not differ significantly between groups at ten weeks.
How this applies: Preparation-specific context; not a directly measured alprazolam interaction.
Regular medication users and people with restless legs syndrome or other sleep disorders were excluded. Exploratory study; internal reporting inconsistencies in analysis counts. Cannot extend to alprazolam-treated patients or leaf preparations.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Current exact claims adjudicated against captured originals and explicit comparator/co-use boundaries. | |
| Research summary published |
Article revision: fe762aed2c13fef0
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.